Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.11 trillion and total revenue of $109.95 billion.
Market Cap
1.11T
Revenue
109.95B
Profits
-41.95B
PE Ratio
n/a
Profit Margin
-38.16%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 125.08B | -1.36% | 2,041,366 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.50B | 0.34% | 391,354 | 14.34B |
| 3 | ARGX | argenx SE | 44.80B | -1.98% | 342,164 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.50B | -0.60% | 904,905 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.16B | -2.12% | 266,861 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.05B | -3.09% | 1,290,002 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.93B | 1.57% | 2,709,316 | 2.38B |
| 8 | MRNA | Moderna, Inc. | 22.10B | 1.80% | 6,828,708 | 1.94B |
| 9 | BNTX | BioNTech SE | 21.80B | 8.28% | 4,539,764 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.17B | -0.40% | 7,331,359 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.74B | 0.74% | 2,293,506 | - |
| 12 | INCY | Incyte Corporation | 18.84B | -1.42% | 1,725,954 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.72B | -2.07% | 1,203,792 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.96B | -5.41% | 839,823 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.84B | -3.94% | 2,478,844 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.47B | -1.53% | 1,823,012 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -1.15% | 1,541,885 | 943.71M |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.60B | -0.94% | 2,521,082 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.42B | -0.27% | 625,750 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 10.84B | 1.11% | 2,280,365 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.90B | -0.29% | 281,252 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 8.67B | -2.58% | 666,775 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.50B | 3.25% | 17,212,171 | 113.29M |
| 24 | TECH | Bio-Techne Corporation | 8.39B | 1.51% | 1,981,736 | 1.22B |
| 25 | PCVX | Vaxcyte, Inc. | 8.28B | -1.22% | 696,474 | - |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.27B | -4.18% | 282,226 | 7.46M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 8.16B | -4.11% | 656,438 | 638.50M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.14B | -1.86% | 2,562,156 | 1.09B |
| 29 | NUVL | Nuvalent, Inc. | 7.87B | -2.16% | 379,077 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.85B | -1.96% | 1,544,479 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.84B | -0.89% | 1,757,298 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.45B | -2.33% | 163,157 | 389.13M |
| 33 | BLTE | Belite Bio, Inc | 6.84B | -0.14% | 59,236 | - |
| 34 | ACLX | Arcellx, Inc. | 6.71B | -0.03% | 795,550 | 22.29M |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.66B | -3.62% | 688,863 | 39.21M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.16B | -0.59% | 788,697 | 46.02M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | -3.21% | 633,743 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.81B | -1.64% | 1,352,791 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 5.54B | 0.90% | 488,171 | 521.31M |
| 40 | CGON | CG Oncology, Inc. | 5.46B | 2.96% | 3,901,023 | 4.04M |
| 41 | PTCT | PTC Therapeutics, Inc. | 5.44B | -4.22% | 905,689 | 1.73B |
| 42 | CELC | Celcuity Inc. | 5.36B | -1.14% | 583,559 | - |
| 43 | CAI | Caris Life Sciences, Inc. | 5.26B | 0.43% | 1,471,081 | 812.03M |
| 44 | IMVT | Immunovant, Inc. | 5.20B | -0.62% | 628,362 | - |
| 45 | APGE | Apogee Therapeutics, Inc. | 5.14B | -0.92% | 714,205 | - |
| 46 | TERN | Terns Pharmaceuticals, Inc. | 5.09B | 3.29% | 1,658,841 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.96B | -3.57% | 805,744 | - |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 4.91B | -2.59% | 5,290,330 | 7.50M |
| 49 | ERAS | Erasca, Inc. | 4.80B | -0.51% | 4,284,126 | - |
| 50 | CRSP | CRISPR Therapeutics AG | 4.79B | -5.44% | 5,816,301 | 3.51M |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.07% | 5,274,506 | 634.21M |
| 52 | LGND | Ligand Pharmaceuticals Incorporated | 4.41B | 4.22% | 386,049 | 268.09M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.14B | -4.17% | 1,259,339 | 616.29M |
| 54 | VKTX | Viking Therapeutics, Inc. | 4.13B | 3.17% | 3,286,406 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 4.13B | 2.39% | 870,303 | 15.00M |
| 56 | GPCR | Structure Therapeutics Inc. | 4.12B | -0.03% | 695,950 | - |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.87B | -0.99% | 734,891 | 7.70M |
| 58 | DNTH | Dianthus Therapeutics, Inc. | 3.82B | -1.24% | 3,023,953 | 2.04M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | -2.53% | 863,074 | 1.07B |
| 60 | LEGN | Legend Biotech Corporation | 3.74B | 3.63% | 1,254,495 | 1.03B |
| 61 | ADMA | ADMA Biologics, Inc. | 3.73B | -1.01% | 2,308,943 | 510.17M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.60B | 0.26% | 605,338 | 22.50M |
| 63 | CORT | Corcept Therapeutics Incorporated | 3.59B | 0.60% | 804,030 | 761.41M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.43B | 0.84% | 1,139,805 | - |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.32B | 5.77% | 965,790 | - |
| 66 | DYN | Dyne Therapeutics, Inc. | 3.30B | 1.06% | 2,903,427 | - |
| 67 | ALMS | Alumis Inc. | 3.28B | -6.26% | 1,002,489 | 22.12M |
| 68 | SYRE | Spyre Therapeutics, Inc. | 3.26B | -0.17% | 571,014 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.06B | -0.57% | 1,348,643 | 247.00M |
| 70 | VERA | Vera Therapeutics, Inc. | 3.00B | 4.45% | 1,291,858 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | -1.99% | 457,430 | 218.71M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.98B | -1.47% | 700,955 | 588.99M |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.97B | -4.30% | 696,516 | 451.36M |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.97B | -2.60% | 628,940 | 376.07M |
| 75 | VRDN | Viridian Therapeutics, Inc. | 2.93B | -1.95% | 1,048,226 | 70.85M |
| 76 | WVE | Wave Life Sciences Ltd. | 2.65B | 2.40% | 1,778,251 | 42.73M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.63B | -0.56% | 870,828 | 490.73M |
| 78 | TLX | Telix Pharmaceuticals Limited | 2.61B | -2.28% | 203,125 | 803.79M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.59B | - | 1,388,811 | 139.74M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.48B | -1.32% | 1,636,134 | 1.00B |
| 81 | IRON | Disc Medicine, Inc. | 2.44B | -3.52% | 381,951 | - |
| 82 | MAZE | Maze Therapeutics, Inc. | 2.43B | -1.20% | 490,715 | 2.50M |
| 83 | TNGX | Tango Therapeutics, Inc. | 2.42B | 2.97% | 3,129,194 | 62.38M |
| 84 | IMNM | Immunome, Inc. | 2.42B | -2.10% | 567,803 | 6.94M |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.21B | -1.62% | 1,260,622 | - |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | -0.14% | 4,954,549 | 158.18M |
| 87 | AAPG | Ascentage Pharma Group International | 2.19B | -1.10% | 1,890 | 54.52M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | -2.07% | 1,771,037 | 276.98M |
| 89 | STOK | Stoke Therapeutics, Inc. | 2.17B | -1.07% | 357,113 | 205.63M |
| 90 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | 1.16% | 1,112,572 | 172.35M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.14B | -2.76% | 3,501,395 | 673.00M |
| 92 | ZLAB | Zai Lab Limited | 2.14B | -2.00% | 293,460 | 460.16M |
| 93 | GLPG | Galapagos NV | 2.14B | -1.84% | 190,961 | 1.31B |
| 94 | CLDX | Celldex Therapeutics, Inc. | 2.08B | 0.26% | 811,688 | 1.55M |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -3.75% | 3,590,106 | 51.95M |
| 96 | NKTR | Nektar Therapeutics | 2.05B | 1.75% | 580,540 | 62.60M |
| 97 | MESO | Mesoblast Limited | 2.02B | -0.70% | 90,985 | 65.38M |
| 98 | SLNO | Soleno Therapeutics, Inc. | 2.02B | -3.84% | 1,265,015 | 190.41M |
| 99 | IOVA | Iovance Biotherapeutics, Inc. | 1.99B | -6.92% | 20,715,379 | 263.50M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | 0.07% | 648,656 | 283.06M |
| 101 | TYRA | Tyra Biosciences, Inc. | 1.97B | 5.18% | 800,527 | - |
| 102 | RLAY | Relay Therapeutics, Inc. | 1.93B | 1.03% | 7,171,552 | 15.36M |
| 103 | MANE | Veradermics, Incorporated | 1.91B | 0.75% | 147,782 | - |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.88B | -1.70% | 220,457 | - |
| 105 | ANAB | AnaptysBio, Inc. | 1.86B | 4.29% | 753,344 | 234.60M |
| 106 | DFTX | Definium Therapeutics, Inc. | 1.86B | -2.20% | 1,271,267 | - |
| 107 | ZYME | Zymeworks Inc. | 1.85B | -1.26% | 689,531 | 105.97M |
| 108 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -0.48% | 2,446,374 | 2.20B |
| 109 | ELVN | Enliven Therapeutics, Inc. | 1.84B | 1.52% | 747,741 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 0.29% | 13,107,950 | 74.68M |
| 111 | PHVS | Pharvaris N.V. | 1.78B | 6.22% | 163,528 | - |
| 112 | NVAX | Novavax, Inc. | 1.76B | 1.03% | 5,177,220 | 1.12B |
| 113 | CAPR | Capricor Therapeutics, Inc. | 1.74B | 0.51% | 1,814,796 | 11.13M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.73B | 0.79% | 186,418 | - |
| 115 | VCEL | Vericel Corporation | 1.67B | -1.56% | 340,072 | 276.26M |
| 116 | ORKA | Oruka Therapeutics, Inc. | 1.67B | 2.14% | 502,916 | - |
| 117 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67B | 0.17% | 544,076 | 868.45M |
| 118 | INVA | Innoviva, Inc. | 1.66B | 0.04% | 466,642 | 411.33M |
| 119 | IMCR | Immunocore Holdings plc | 1.65B | -2.46% | 290,740 | 400.02M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -0.67% | 430,070 | 54.03M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.64B | 0.31% | 773,857 | 83.98M |
| 122 | NBTX | Nanobiotix S.A. | 1.63B | -14.00% | 91,039 | 11.93M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.62B | 4.18% | 775,824 | 31.89M |
| 124 | OCS | Oculis Holding AG | 1.61B | -4.78% | 368,407 | 1.51M |
| 125 | NUVB | Nuvation Bio Inc. | 1.57B | -2.13% | 4,759,106 | 62.90M |
| 126 | BHVN | Biohaven Ltd. | 1.57B | 1.85% | 2,059,422 | - |
| 127 | VIR | Vir Biotechnology, Inc. | 1.57B | -0.61% | 3,821,015 | 68.56M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.54B | -3.41% | 2,813,075 | 67.67M |
| 129 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 1.53% | 779,246 | - |
| 130 | KOD | Kodiak Sciences Inc. | 1.52B | -2.27% | 484,852 | - |
| 131 | ATAI | AtaiBeckley Inc. | 1.48B | -1.93% | 4,310,782 | 4.09M |
| 132 | ARDX | Ardelyx, Inc. | 1.47B | -2.12% | 2,011,569 | 407.32M |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.46B | 3.07% | 303,598 | - |
| 134 | CRVS | Corvus Pharmaceuticals, Inc. | 1.42B | 0.72% | 704,268 | - |
| 135 | SVRA | Savara Inc. | 1.37B | -1.43% | 726,267 | - |
| 136 | MBX | MBX Biosciences, Inc. | 1.36B | -0.24% | 447,253 | - |
| 137 | ZBIO | Zenas BioPharma, Inc. | 1.36B | -2.24% | 229,311 | 15.00M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -1.27% | 715,180 | 181.54M |
| 139 | IMTX | Immatics N.V. | 1.34B | -4.48% | 4,230,999 | 56.67M |
| 140 | BCAX | Bicara Therapeutics Inc. | 1.29B | -0.80% | 388,022 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.28B | -2.73% | 677,918 | - |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | - | 1,348,228 | - |
| 143 | DBVT | DBV Technologies S.A. | 1.25B | -12.02% | 703,804 | 5.50M |
| 144 | EYPT | EyePoint, Inc. | 1.24B | -3.37% | 1,072,678 | 31.37M |
| 145 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -1.20% | 2,218,813 | 6.31M |
| 146 | IVA | Inventiva S.A. | 1.23B | 1.06% | 292,929 | 19.93M |
| 147 | OLMA | Olema Pharmaceuticals, Inc. | 1.23B | -0.95% | 1,909,061 | - |
| 148 | PGEN | Precigen, Inc. | 1.21B | -2.56% | 1,639,815 | 6.31M |
| 149 | SEPN | Septerna, Inc. | 1.18B | -6.10% | 261,117 | 45.95M |
| 150 | ABCL | AbCellera Biologics Inc. | 1.11B | 2.24% | 1,542,981 | 75.13M |
| 151 | QURE | uniQure N.V. | 1.10B | -3.83% | 2,676,251 | 16.10M |
| 152 | PHAR | Pharming Group N.V. | 1.09B | -4.74% | 9,803 | 362.27M |
| 153 | AVBP | ArriVent BioPharma, Inc. | 1.09B | -2.84% | 456,978 | - |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.07B | 2.61% | 122,565 | 1.40M |
| 155 | GERN | Geron Corporation | 1.06B | 1.84% | 20,743,498 | 183.88M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.02B | 2.27% | 227,497 | 5.56M |
| 157 | CMPX | Compass Therapeutics, Inc. | 1.01B | 0.36% | 1,258,769 | 850.00K |
| 158 | XERS | Xeris Biopharma Holdings, Inc. | 988.03M | -1.55% | 1,566,987 | 291.85M |
| 159 | VALN | Valneva SE | 961.97M | -1.32% | 8,616 | 211.09M |
| 160 | GHRS | GH Research PLC | 938.50M | -4.00% | 137,294 | - |
| 161 | SLS | SELLAS Life Sciences Group, Inc. | 933.15M | -5.84% | 6,191,430 | - |
| 162 | KALV | KalVista Pharmaceuticals, Inc. | 921.96M | -1.08% | 1,144,647 | 1.43M |
| 163 | URGN | UroGen Pharma Ltd. | 917.17M | -3.14% | 453,053 | 109.79M |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 912.59M | 1.43% | 1,181,875 | 185.74M |
| 165 | ABUS | Arbutus Biopharma Corporation | 907.77M | 0.21% | 1,502,640 | 14.61M |
| 166 | SGP | SpyGlass Pharma, Inc. | 902.90M | 1.04% | 150,724 | - |
| 167 | ANNX | Annexon, Inc. | 898.81M | -0.82% | 1,126,045 | - |
| 168 | XNCR | Xencor, Inc. | 883.00M | 0.50% | 646,066 | 125.58M |
| 169 | FTRE | Fortrea Holdings Inc. | 880.77M | 5.25% | 1,876,298 | 2.72B |
| 170 | PHAT | Phathom Pharmaceuticals, Inc. | 878.21M | 0.32% | 1,078,641 | 175.11M |
| 171 | MNKD | MannKind Corporation | 868.84M | 8.05% | 7,277,835 | 348.97M |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 866.13M | -4.02% | 719,804 | - |
| 173 | ARVN | Arvinas, Inc. | 862.19M | -2.53% | 524,876 | 262.60M |
| 174 | JANX | Janux Therapeutics, Inc. | 856.51M | 0.07% | 564,637 | 10.00M |
| 175 | OMER | Omeros Corporation | 845.84M | 1.88% | 546,872 | - |
| 176 | EVMN | Evommune, Inc. | 842.83M | -2.50% | 149,195 | 13.00M |
| 177 | SANA | Sana Biotechnology, Inc. | 840.63M | -4.26% | 2,243,994 | - |
| 178 | SPRY | ARS Pharmaceuticals, Inc. | 832.11M | -5.42% | 1,415,699 | 84.28M |
| 179 | CTMX | CytomX Therapeutics, Inc. | 826.84M | - | 1,494,623 | 113.63M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 825.26M | -0.32% | 104,939 | - |
| 181 | KURA | Kura Oncology, Inc. | 814.40M | -0.43% | 1,487,258 | 67.48M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 809.93M | -4.77% | 196,520 | - |
| 183 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 799.53M | -1.96% | 114,507 | - |
| 184 | GYRE | Gyre Therapeutics, Inc. | 757.12M | 2.59% | 83,313 | 107.27M |
| 185 | OCGN | Ocugen, Inc. | 754.16M | 29.94% | 40,412,369 | 4.41M |
| 186 | PROK | ProKidney Corp. | 740.05M | -0.81% | 290,666 | 744.00K |
| 187 | TENX | Tenax Therapeutics, Inc. | 735.39M | 0.76% | 834,131 | - |
| 188 | LXRX | Lexicon Pharmaceuticals, Inc. | 728.73M | 3.61% | 2,420,884 | 49.80M |
| 189 | ANRO | Alto Neuroscience, Inc. | 716.08M | 10.39% | 410,680 | - |
| 190 | EIKN | Eikon Therapeutics, Inc. | 711.51M | -5.99% | 394,614 | - |
| 191 | TBPH | Theravance Biopharma, Inc. | 699.79M | -1.57% | 519,820 | 80.33M |
| 192 | JBIO | Jade Biosciences, Inc. | 691.41M | -3.18% | 266,375 | - |
| 193 | PRME | Prime Medicine, Inc. | 678.21M | -5.43% | 2,372,815 | 4.63M |
| 194 | MDXG | MiMedx Group, Inc. | 677.46M | -0.22% | 810,348 | 418.63M |
| 195 | ZURA | Zura Bio Limited | 663.18M | 1.30% | 282,141 | - |
| 196 | AGMB | AgomAb Therapeutics NV | 661.36M | -1.31% | 40,993 | - |
| 197 | TECX | Tectonic Therapeutic, Inc. | 653.24M | 4.66% | 415,086 | - |
| 198 | REPL | Replimune Group, Inc. | 652.32M | -4.01% | 1,114,151 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 628.63M | 0.64% | 260,011 | 27.42M |
| 200 | LBRX | LB Pharmaceuticals Inc | 624.38M | 2.75% | 297,872 | - |
| 201 | ADCT | ADC Therapeutics SA | 619.98M | 1.67% | 1,270,671 | 81.36M |
| 202 | DRTS | Alpha Tau Medical Ltd. | 619.59M | 2.92% | 218,025 | - |
| 203 | VOR | Vor Biopharma Inc. | 617.82M | -7.00% | 596,644 | - |
| 204 | DSGN | Design Therapeutics, Inc. | 617.34M | 0.20% | 155,227 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 611.19M | -5.88% | 4,233,518 | 106.47M |
| 206 | SLDB | Solid Biosciences Inc. | 601.08M | -5.68% | 4,257,059 | - |
| 207 | ALLO | Allogene Therapeutics, Inc. | 591.04M | -2.95% | 2,920,378 | 22.00K |
| 208 | LRMR | Larimar Therapeutics, Inc. | 588.56M | -3.39% | 1,292,672 | - |
| 209 | NMRA | Neumora Therapeutics, Inc. | 573.54M | 3.53% | 1,633,998 | - |
| 210 | CTNM | Contineum Therapeutics, Inc. | 559.29M | 11.71% | 250,482 | - |
| 211 | IMMX | Immix Biopharma, Inc. | 551.20M | 0.58% | 729,346 | - |
| 212 | YDES | YD Bio Limited | 549.20M | 1.87% | 6,233 | 510.36K |
| 213 | VNDA | Vanda Pharmaceuticals Inc. | 549.11M | -2.82% | 1,900,384 | 216.11M |
| 214 | VSTM | Verastem, Inc. | 543.70M | -3.13% | 802,550 | 30.91M |
| 215 | RCKT | Rocket Pharmaceuticals, Inc. | 538.50M | -6.42% | 3,778,498 | - |
| 216 | IVVD | Invivyd, Inc. | 536.93M | 3.83% | 2,146,382 | 53.43M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 534.07M | -1.91% | 138,224 | 41.00K |
| 218 | CRMD | CorMedix Inc. | 528.85M | -0.45% | 1,395,637 | 311.71M |
| 219 | FULC | Fulcrum Therapeutics, Inc. | 518.82M | -2.75% | 937,937 | 80.00M |
| 220 | PRTA | Prothena Corporation plc | 515.72M | -1.94% | 614,910 | 9.68M |
| 221 | UPB | Upstream Bio, Inc. | 505.80M | 15.27% | 1,690,327 | 2.80M |
| 222 | RIGL | Rigel Pharmaceuticals, Inc. | 503.39M | -4.18% | 343,062 | 294.28M |
| 223 | KYTX | Kyverna Therapeutics, Inc. | 502.17M | -4.77% | 578,905 | - |
| 224 | LXEO | Lexeo Therapeutics, Inc. | 499.96M | -4.86% | 651,462 | - |
| 225 | ALT | Altimmune, Inc. | 494.27M | -1.55% | 2,883,491 | 41.00K |
| 226 | IPSC | Century Therapeutics, Inc. | 490.44M | -1.44% | 1,044,890 | 113.34M |
| 227 | FBRX | Forte Biosciences, Inc. | 488.22M | -3.15% | 189,410 | - |
| 228 | TRDA | Entrada Therapeutics, Inc. | 486.00M | 2.27% | 210,879 | 25.42M |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 486.00M | 0.83% | 667,088 | - |
| 230 | RGNX | REGENXBIO Inc. | 484.13M | -5.25% | 631,473 | 170.44M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.05M | -4.11% | 180,945 | - |
| 232 | ACRS | Aclaris Therapeutics, Inc. | 479.86M | -1.91% | 1,868,097 | 7.83M |
| 233 | RLMD | Relmada Therapeutics, Inc. | 463.47M | -4.53% | 2,009,813 | - |
| 234 | ASMB | Assembly Biosciences, Inc. | 462.02M | -1.32% | 60,160 | 37.19M |
| 235 | ENGN | enGene Holdings Inc. | 460.89M | -0.86% | 712,730 | - |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 435.61M | -3.72% | 405,182 | 120.00K |
| 237 | VTVT | vTv Therapeutics Inc. | 435.55M | 0.23% | 137,886 | 17.00K |
| 238 | PEPG | PepGen Inc. | 434.74M | 2.11% | 687,725 | - |
| 239 | AVXL | Anavex Life Sciences Corp. | 430.92M | 0.22% | 593,775 | - |
| 240 | STTK | Shattuck Labs, Inc. | 420.80M | -1.34% | 360,908 | 1.00M |
| 241 | BNTC | Benitec Biopharma Inc. | 420.65M | 0.08% | 149,210 | - |
| 242 | ARMP | Armata Pharmaceuticals, Inc. | 418.68M | -3.85% | 27,138 | 5.05M |
| 243 | LCTX | Lineage Cell Therapeutics, Inc. | 418.47M | -7.18% | 1,573,071 | 14.56M |
| 244 | AUTL | Autolus Therapeutics plc | 415.18M | -2.50% | 1,185,991 | 51.13M |
| 245 | DMAC | DiaMedica Therapeutics Inc. | 413.63M | -2.89% | 112,975 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 411.20M | 1.58% | 102,999 | 66.98M |
| 247 | IMMP | Immutep Limited | 408.45M | - | 5 | 5.28M |
| 248 | PRTC | PureTech Health plc | 405.78M | -2.12% | 1,143 | 6.39M |
| 249 | STRO | Sutro Biopharma, Inc. | 402.16M | -3.50% | 48,766 | 105.65M |
| 250 | DNA | Ginkgo Bioworks Holdings, Inc. | 397.56M | 7.73% | 1,004,115 | 170.16M |
| 251 | CBIO | Crescent Biopharma, Inc. | 394.58M | -5.34% | 120,483 | 10.84M |
| 252 | NAGE | Niagen Bioscience, Inc. | 392.41M | -6.32% | 1,774,212 | 129.42M |
| 253 | MNPR | Monopar Therapeutics Inc. | 380.91M | -2.58% | 179,485 | - |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 378.60M | -7.08% | 610,372 | 33.98M |
| 255 | LENZ | LENZ Therapeutics, Inc. | 376.11M | 0.67% | 348,855 | 17.50M |
| 256 | CADL | Candel Therapeutics, Inc. | 373.56M | -0.20% | 856,596 | - |
| 257 | NBP | NovaBridge Biosciences | 371.24M | -0.62% | 489,570 | - |
| 258 | ABSI | Absci Corporation | 368.41M | -3.54% | 2,112,586 | 2.82M |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 368.12M | -1.37% | 105,485 | - |
| 260 | IMRX | Immuneering Corporation | 365.29M | 0.53% | 521,176 | - |
| 261 | BCYC | Bicycle Therapeutics plc | 364.18M | -0.94% | 167,160 | 28.34M |
| 262 | AURA | Aura Biosciences, Inc. | 360.06M | 0.53% | 188,230 | - |
| 263 | NGNE | Neurogene Inc. | 356.73M | -0.17% | 61,596 | 925.00K |
| 264 | IRD | Opus Genetics, Inc. | 350.17M | 3.30% | 2,009,784 | 14.20M |
| 265 | CLYM | Climb Bio, Inc. | 350.14M | - | 657,617 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 330.99M | 2.91% | 107,566 | 24.52M |
| 267 | RZLT | Rezolute, Inc. | 330.31M | -0.93% | 1,221,570 | - |
| 268 | SLN | Silence Therapeutics plc | 329.69M | 11.32% | 258,230 | 559.00K |
| 269 | ANL | Adlai Nortye Ltd. | 325.46M | -0.90% | 79,892 | -1.35M |
| 270 | XOMA | XOMA Royalty Corporation | 320.51M | -1.17% | 134,173 | 47.11M |
| 271 | AVTX | Avalo Therapeutics, Inc. | 316.57M | 1.03% | 1,311,237 | 192.00K |
| 272 | NERV | Minerva Neurosciences, Inc. | 315.90M | -8.06% | 222,155 | - |
| 273 | CABA | Cabaletta Bio, Inc. | 314.79M | -1.51% | 1,537,181 | - |
| 274 | PRLD | Prelude Therapeutics Incorporated | 313.93M | 5.83% | 600,788 | 12.14M |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 306.29M | -0.41% | 108,609 | - |
| 276 | PBYI | Puma Biotechnology, Inc. | 305.26M | -0.99% | 340,410 | 228.37M |
| 277 | TARA | Protara Therapeutics, Inc. | 302.87M | -1.93% | 748,392 | - |
| 278 | ACIU | AC Immune SA | 302.77M | 0.66% | 329,295 | 5.48M |
| 279 | PALI | Palisade Bio, Inc. | 298.01M | 4.17% | 3,716,169 | - |
| 280 | ALDX | Aldeyra Therapeutics, Inc. | 297.30M | -1.40% | 1,551,473 | - |
| 281 | CCCC | C4 Therapeutics, Inc. | 291.76M | -4.17% | 3,634,799 | 35.95M |
| 282 | CNTX | Context Therapeutics Inc. | 291.26M | 8.56% | 1,096,824 | - |
| 283 | CAMP | Camp4 Therapeutics Corporation | 290.75M | -7.44% | 376,962 | 3.50M |
| 284 | VYGR | Voyager Therapeutics, Inc. | 289.06M | -3.00% | 1,613,039 | 40.37M |
| 285 | OABI | OmniAb, Inc. | 283.05M | -1.76% | 167,315 | 18.67M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 282.96M | 5.39% | 334,548 | - |
| 287 | CLLS | Cellectis S.A. | 282.07M | -0.52% | 30,026 | 82.55M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 276.30M | 3.59% | 762,991 | 1.00 |
| 289 | CBUS | Cibus, Inc. | 273.60M | 2.02% | 489,501 | 3.79M |
| 290 | PLYX | Polaryx Therapeutics, Inc. | 272.70M | -3.52% | 2,026,007 | - |
| 291 | FENC | Fennec Pharmaceuticals Inc. | 272.20M | 1.01% | 68,518 | 38.79M |
| 292 | ABEO | Abeona Therapeutics Inc. | 271.50M | -2.53% | 1,514,739 | 400.00K |
| 293 | OVID | Ovid Therapeutics Inc. | 269.48M | -2.82% | 1,616,875 | 6.61M |
| 294 | HELP | Cybin Inc. | 269.19M | -6.27% | 770,194 | - |
| 295 | CHRS | Coherus Oncology, Inc. | 266.80M | -8.72% | 1,398,579 | 42.17M |
| 296 | ENLV | Enlivex Ltd. | 265.87M | -3.45% | 109,658 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 263.34M | 6.57% | 16,106 | 18.97M |
| 298 | EDIT | Editas Medicine, Inc. | 260.34M | 0.76% | 1,971,005 | 40.52M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 259.74M | -0.86% | 129,182 | 2.82M |
| 300 | ALEC | Alector, Inc. | 256.04M | -2.52% | 812,320 | 21.05M |
| 301 | SRZN | Surrozen, Inc. | 251.30M | -2.83% | 59,708 | 3.60M |
| 302 | NVCT | Nuvectis Pharma, Inc. | 247.17M | -3.32% | 39,407 | - |
| 303 | CNTN | Canton Strategic Holdings, Inc. | 239.56M | -0.21% | 251,239 | - |
| 304 | SABS | SAB Biotherapeutics, Inc. | 233.36M | 11.71% | 2,799,319 | 114.70K |
| 305 | ACHV | Achieve Life Sciences, Inc. | 233.16M | 2.34% | 321,423 | - |
| 306 | PLX | Protalix BioTherapeutics, Inc. | 232.42M | -0.34% | 388,145 | 61.84M |
| 307 | HUMA | Humacyte, Inc. | 229.67M | -4.03% | 3,240,652 | 1.57M |
| 308 | KROS | Keros Therapeutics, Inc. | 222.22M | -2.68% | 625,841 | 244.06M |
| 309 | MDWD | MediWound Ltd. | 221.20M | -0.86% | 32,695 | 16.96M |
| 310 | ELDN | Eledon Pharmaceuticals, Inc. | 219.01M | -4.83% | 1,235,505 | - |
| 311 | RNAC | Cartesian Therapeutics, Inc. | 218.96M | -3.39% | 181,685 | 2.80M |
| 312 | CGEN | Compugen Ltd. | 215.58M | 1.79% | 424,577 | 72.76M |
| 313 | MGNX | MacroGenics, Inc. | 212.28M | -2.62% | 3,988,800 | 149.50M |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 212.04M | -2.10% | 568,294 | 82.03M |
| 315 | ELTX | Elicio Therapeutics, Inc. | 206.03M | -8.60% | 266,653 | - |
| 316 | ABOS | Acumen Pharmaceuticals, Inc. | 204.13M | 0.30% | 275,188 | - |
| 317 | GALT | Galectin Therapeutics Inc. | 194.06M | -1.63% | 482,106 | - |
| 318 | ZNTL | Zentalis Pharmaceuticals, Inc. | 191.66M | -3.27% | 906,643 | 26.87M |
| 319 | PRQR | ProQR Therapeutics N.V. | 190.67M | 0.56% | 171,157 | 18.86M |
| 320 | CRBU | Caribou Biosciences, Inc. | 190.38M | -2.96% | 977,230 | 11.16M |
| 321 | IMUX | Immunic, Inc. | 189.17M | 12.40% | 5,172,299 | - |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 188.98M | -0.50% | 202,189 | 14.38M |
| 323 | NTHI | NeOnc Technologies Holdings, Inc. | 187.04M | -0.11% | 13,768 | 59.99K |
| 324 | SGMT | Sagimet Biosciences Inc. | 186.67M | 3.80% | 360,132 | - |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 185.91M | -4.06% | 5,632,311 | - |
| 326 | VXRT | Vaxart, Inc. | 185.42M | 0.29% | - | 148.20M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 184.99M | 3.88% | 269,015 | - |
| 328 | HRTX | Heron Therapeutics, Inc. | 182.88M | -1.84% | 1,055,908 | 154.90M |
| 329 | MOLN | Molecular Partners AG | 180.68M | -2.25% | 969 | 856.30K |
| 330 | PMN | ProMIS Neurosciences, Inc. | 180.16M | -7.38% | 38,035 | - |
| 331 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.86M | -1.34% | 189,221 | 10.30M |
| 332 | ARTV | Artiva Biotherapeutics, Inc. | 175.01M | 17.27% | 833,862 | 251.00K |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 173.71M | -3.93% | 1,168,080 | - |
| 334 | KLRS | Kalaris Therapeutics, Inc. | 172.90M | -7.18% | 31,729 | - |
| 335 | NKTX | Nkarta, Inc. | 172.60M | -5.45% | 657,101 | - |
| 336 | MENS | Jyong Biotech Ltd. | 171.49M | -8.61% | 225,462 | - |
| 337 | CNTB | Connect Biopharma Holdings Limited | 168.83M | 8.24% | 241,044 | 762.00K |
| 338 | ADAG | Adagene Inc. | 167.32M | 21.16% | 2,123,458 | 103.20K |
| 339 | TLSA | Tiziana Life Sciences Ltd | 167.19M | -4.38% | 142,620 | - |
| 340 | RANI | Rani Therapeutics Holdings, Inc. | 166.48M | 3.01% | 379,125 | 1.20M |
| 341 | KPTI | Karyopharm Therapeutics Inc. | 160.51M | 6.32% | 460,873 | 146.07M |
| 342 | SGMO | Sangamo Therapeutics, Inc. | 152.17M | -1.09% | 2,121,746 | 32.88M |
| 343 | UNCY | Unicycive Therapeutics, Inc. | 151.30M | 1.29% | 221,870 | - |
| 344 | IPHA | Innate Pharma S.A. | 146.43M | -5.49% | 49,401 | 14.84M |
| 345 | SPRO | Spero Therapeutics, Inc. | 145.92M | 5.71% | 617,736 | 40.55M |
| 346 | FATE | Fate Therapeutics, Inc. | 143.00M | -4.65% | 1,311,581 | 6.65M |
| 347 | ANTX | AN2 Therapeutics, Inc. | 139.48M | -6.78% | 1,521,823 | - |
| 348 | CRDF | Cardiff Oncology, Inc. | 137.41M | -0.50% | 597,352 | 593.00K |
| 349 | ORMP | Oramed Pharmaceuticals Inc. | 135.33M | 2.10% | 107,966 | 2.00M |
| 350 | ACOG | Alpha Cognition Inc. | 128.28M | 0.17% | 24,551 | 7.43M |
| 351 | BDTX | Black Diamond Therapeutics, Inc. | 128.19M | -0.88% | 472,863 | 70.00M |
| 352 | GNLX | Genelux Corporation | 123.11M | -0.71% | 100,199 | 8.00K |
| 353 | DTIL | Precision BioSciences, Inc. | 121.80M | -5.42% | 235,738 | 698.00K |
| 354 | HURA | TuHURA Biosciences, Inc. | 121.44M | 11.11% | 2,279,266 | - |
| 355 | EQ | Equillium, Inc. | 121.18M | 1.02% | 230,164 | 4.39M |
| 356 | KRRO | Korro Bio, Inc. | 116.67M | 2.44% | 181,537 | 7.37M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 116.11M | -2.31% | 1,092,515 | 182.34K |
| 358 | COYA | Coya Therapeutics, Inc. | 115.59M | 0.61% | 121,911 | 3.99M |
| 359 | CDXS | Codexis, Inc. | 114.71M | 2.42% | 8,158,862 | 52.93M |
| 360 | GOSS | Gossamer Bio, Inc. | 113.44M | -3.35% | 7,888,575 | 44.05M |
| 361 | AARD | Aardvark Therapeutics, Inc. | 113.22M | -10.19% | 821,483 | - |
| 362 | AGEN | Agenus Inc. | 112.57M | -1.78% | 282,225 | 106.83M |
| 363 | GANX | Gain Therapeutics, Inc. | 109.23M | 0.35% | 663,802 | - |
| 364 | ONCY | Oncolytics Biotech Inc. | 108.68M | -0.98% | 832,579 | - |
| 365 | BMEA | Biomea Fusion, Inc. | 106.06M | 2.04% | 556,195 | - |
| 366 | TTRX | Turn Therapeutics Inc. | 105.56M | 2.43% | 6,156 | - |
| 367 | QTTB | Q32 Bio Inc. | 101.09M | 15.36% | 538,802 | 53.74M |
| 368 | CGTX | Cognition Therapeutics, Inc. | 100.63M | 1.79% | 320,277 | - |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 100.10M | 4.68% | 221,369 | 30.83M |
| 370 | FBIO | Fortress Biotech, Inc. | 99.94M | -4.17% | 320,267 | 62.30M |
| 371 | SEER | Seer, Inc. | 99.30M | -0.56% | 104,233 | 16.58M |
| 372 | ANIX | Anixa Biosciences, Inc. | 98.57M | -1.34% | 47,735 | - |
| 373 | PYXS | Pyxis Oncology, Inc. | 97.13M | 0.65% | 175,619 | 2.82M |
| 374 | DWTX | Dogwood Therapeutics, Inc. | 93.56M | -9.35% | 92,142 | - |
| 375 | MAIA | MAIA Biotechnology, Inc. | 92.10M | 4.67% | 1,118,626 | - |
| 376 | VANI | Vivani Medical, Inc. | 91.03M | -2.56% | 198,424 | - |
| 377 | ATYR | aTyr Pharma, Inc. | 90.39M | -1.49% | 562,746 | 190.00K |
| 378 | CING | Cingulate Inc. | 88.66M | 8.13% | 643,516 | - |
| 379 | KZIA | Kazia Therapeutics Limited | 88.37M | -4.81% | 114,647 | 1.20M |
| 380 | SPRB | Spruce Biosciences, Inc. | 88.06M | 2.21% | 36,692 | 697.00K |
| 381 | OKYO | OKYO Pharma Limited | 87.84M | 0.59% | 42,830 | - |
| 382 | PMVP | PMV Pharmaceuticals, Inc. | 85.33M | -1.23% | 411,442 | - |
| 383 | IBIO | iBio, Inc. | 83.94M | 2.10% | 896,277 | 300.00K |
| 384 | PYPD | PolyPid Ltd. | 83.01M | 0.69% | 42,535 | - |
| 385 | CSBR | Champions Oncology, Inc. | 81.93M | - | 3,461 | 58.42M |
| 386 | PLRX | Pliant Therapeutics, Inc. | 81.73M | -4.32% | 289,680 | - |
| 387 | MCRB | Seres Therapeutics, Inc. | 80.79M | -0.22% | 24,893 | 351.00K |
| 388 | ACET | Adicet Bio, Inc. | 75.49M | -0.80% | 169,112 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 75.23M | -8.14% | 1,283 | 7.41M |
| 390 | GUTS | Fractyl Health, Inc. | 72.10M | -3.33% | 1,847,221 | 3.00K |
| 391 | XBIT | XBiotech Inc. | 71.34M | 0.43% | 25,217 | - |
| 392 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.89M | -1.15% | 87,748 | 501.00K |
| 393 | MNOV | MediciNova, Inc. | 69.89M | 0.71% | 29,641 | 409.66K |
| 394 | NRXS | NeurAxis, Inc. | 68.71M | 2.22% | 221,792 | 3.36M |
| 395 | ANVS | Annovis Bio, Inc. | 66.26M | -3.10% | 435,024 | - |
| 396 | TCRX | TScan Therapeutics, Inc. | 65.44M | -2.54% | 280,706 | 10.33M |
| 397 | IFRX | InflaRx N.V. | 65.17M | 3.44% | 66,844 | 73.73K |
| 398 | LONA | LeonaBio, Inc. | 64.51M | 7.47% | 35,076 | - |
| 399 | ENTX | Entera Bio Ltd. | 64.43M | -5.70% | 224,738 | 124.00K |
| 400 | IMA | ImageneBio, Inc. | 64.01M | -0.99% | 42,871 | 800.00K |
| 401 | MREO | Mereo BioPharma Group plc | 63.49M | -0.18% | 1,378,016 | 500.00K |
| 402 | EXOZ | eXoZymes, Inc. | 62.67M | 2.19% | 1,631 | -700.00 |
| 403 | ATHE | Alterity Therapeutics Limited | 62.14M | -1.38% | 16,263 | 4.43M |
| 404 | BYSI | BeyondSpring Inc. | 62.09M | 2.72% | 21,643 | 1.88M |
| 405 | MGX | Metagenomi Therapeutics, Inc. | 61.70M | -6.82% | 313,726 | 25.21M |
| 406 | TIL | Instil Bio, Inc. | 61.24M | 1.12% | 12,549 | - |
| 407 | GRCE | Grace Therapeutics, Inc. | 61.12M | - | 364,174 | - |
| 408 | ICCC | ImmuCell Corporation | 60.15M | 0.30% | 9,373 | 27.64M |
| 409 | HYFT | MindWalk Holdings Corp. | 59.76M | -1.54% | 460,290 | 19.02M |
| 410 | NRXP | NRx Pharmaceuticals, Inc. | 58.65M | 1.66% | 252,226 | 242.00K |
| 411 | ACTU | Actuate Therapeutics, Inc. | 58.57M | -11.27% | 96,928 | - |
| 412 | IBO | Impact BioMedical Inc. | 57.54M | -9.54% | 403,541 | 25.00K |
| 413 | KLTO | Klotho Neurosciences, Inc. | 56.66M | 0.81% | 2,251,279 | - |
| 414 | RADX | Radiopharm Theranostics Limited | 55.69M | -0.60% | 18,412 | 10.86M |
| 415 | EDSA | Edesa Biotech, Inc. | 55.26M | -4.06% | 1,151,399 | - |
| 416 | OSTX | OS Therapies Incorporated | 54.58M | -4.91% | 714,128 | - |
| 417 | PSTV | Plus Therapeutics, Inc. | 54.43M | 1.72% | 1,800,234 | 5.26M |
| 418 | RLYB | Rallybio Corporation | 52.50M | -0.75% | 91,614 | 674.00K |
| 419 | INKT | MiNK Therapeutics, Inc. | 52.48M | -17.25% | 385,365 | - |
| 420 | ACRV | Acrivon Therapeutics, Inc. | 51.43M | -1.81% | 428,465 | - |
| 421 | KZR | Kezar Life Sciences, Inc. | 51.41M | -1.54% | 2,922 | - |
| 422 | ESLA | Estrella Immunopharma, Inc. | 51.28M | - | 14,335 | - |
| 423 | LPCN | Lipocine Inc. | 49.91M | 10.85% | 101,116 | 1.98M |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | 9.23% | 119,905 | - |
| 425 | NXTC | NextCure, Inc. | 48.42M | 7.00% | 47,055 | - |
| 426 | NTRB | Nutriband Inc. | 47.83M | -2.11% | 21,677 | 2.28M |
| 427 | OKUR | OnKure Therapeutics, Inc. | 47.83M | -0.28% | 140,653 | - |
| 428 | ALGS | Aligos Therapeutics, Inc. | 46.66M | 6.20% | 46,684 | 2.19M |
| 429 | ATRA | Atara Biotherapeutics, Inc. | 44.92M | -0.95% | 378,796 | 151.93M |
| 430 | LSTA | Lisata Therapeutics, Inc. | 44.37M | - | 104,221 | 1.07M |
| 431 | APLM | Apollomics, Inc. | 43.78M | 2.36% | 5,916 | 6.93M |
| 432 | LITS | Lite Strategy, Inc. | 42.54M | - | 167,392 | - |
| 433 | ATOS | Atossa Therapeutics, Inc. | 41.16M | - | 42,675 | - |
| 434 | CRVO | CervoMed Inc. | 40.90M | -9.05% | 125,957 | 6.16M |
| 435 | HOWL | Werewolf Therapeutics, Inc. | 40.65M | 13.18% | 813,656 | 1.14M |
| 436 | VERU | Veru Inc. | 40.61M | 2.43% | 48,374 | 16.89M |
| 437 | XLO | Xilio Therapeutics, Inc. | 39.67M | -3.57% | 279,398 | 31.80M |
| 438 | PTN | Palatin Technologies, Inc. | 38.46M | -1.49% | 18,002 | 8.96M |
| 439 | INMB | INmune Bio Inc. | 37.75M | 10.94% | 974,457 | 50.00K |
| 440 | JSPR | Jasper Therapeutics, Inc. | 37.50M | -2.19% | 152,214 | - |
| 441 | PDSB | PDS Biotechnology Corporation | 37.47M | -0.31% | 113,609 | - |
| 442 | SNSE | Sensei Biotherapeutics, Inc. | 37.17M | -2.10% | 128,255 | - |
| 443 | CELU | Celularity Inc. | 36.91M | -7.91% | 334,920 | 40.58M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 36.81M | -2.48% | 67,127 | 90.00K |
| 445 | OTLK | Outlook Therapeutics, Inc. | 36.06M | -2.45% | 653,423 | 205.70K |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 35.46M | -1.31% | 31,137 | - |
| 447 | ABVC | ABVC BioPharma, Inc. | 35.09M | -2.74% | 50,192 | 797.92K |
| 448 | PLUR | Pluri Inc. | 33.98M | -0.55% | 3,124 | 1.34M |
| 449 | NBY | NovaBay Pharmaceuticals, Inc. | 33.18M | 0.79% | 239,351 | 10.30M |
| 450 | RNTX | Rein Therapeutics Inc. | 33.12M | 0.80% | 80,574 | - |
| 451 | TPST | Tempest Therapeutics, Inc. | 32.35M | - | 42,951 | - |
| 452 | EVAX | Evaxion A/S | 32.28M | 8.10% | 43,483 | 7.53M |
| 453 | CUE | Cue Biopharma, Inc. | 31.67M | 4.81% | 2,222,779 | 7.10M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 31.46M | 13.91% | 609,557 | - |
| 455 | TVGN | Tevogen Bio Holdings Inc. | 30.28M | -3.98% | 27,245 | - |
| 456 | LTRN | Lantern Pharma Inc. | 30.20M | -2.17% | 31,801 | - |
| 457 | CVM | CEL-SCI Corporation | 29.94M | - | 14,614 | - |
| 458 | AEON | AEON Biopharma, Inc. | 29.35M | 0.87% | 72,160 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 29.26M | 0.89% | 63,991 | - |
| 460 | RNXT | RenovoRx, Inc. | 29.14M | -3.04% | 80,693 | 928.00K |
| 461 | DYAI | Dyadic International, Inc. | 28.99M | -3.49% | 22,680 | 3.34M |
| 462 | KYNB | Kyntra Bio, Inc. | 28.80M | -0.14% | 7,430 | 8.30M |
| 463 | HYPD | Hyperion DeFi, Inc. | 28.38M | 2.74% | 432,970 | 345.32K |
| 464 | IGC | IGC Pharma, Inc. | 27.84M | 1.96% | 68,117 | 1.11M |
| 465 | PASG | Passage Bio, Inc. | 27.11M | -0.71% | 120,803 | - |
| 466 | LIXT | Lixte Biotechnology Holdings, Inc. | 27.01M | 20.62% | 42,227 | - |
| 467 | SNTI | Senti Biosciences, Inc. | 26.55M | 1.68% | 92,446 | - |
| 468 | XCUR | Exicure, Inc. | 26.32M | 0.24% | 17,487 | 500.00K |
| 469 | BOLD | Boundless Bio, Inc. | 25.97M | 0.87% | 48,243 | - |
| 470 | BRNS | Barinthus Biotherapeutics plc | 25.93M | 12.39% | 11,209 | 14.97M |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 25.66M | 2.37% | 61,921 | 14.99M |
| 472 | NNVC | NanoViricides, Inc. | 24.83M | 18.32% | 999,960 | - |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 23.68M | -2.19% | 551,171 | 789.00K |
| 474 | SKYE | Skye Bioscience, Inc. | 23.12M | -9.70% | 1,434,571 | - |
| 475 | FBLG | FibroBiologics, Inc. | 23.00M | -14.11% | 1,426,735 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.84M | -2.84% | 103,932 | 4.69M |
| 477 | DARE | Daré Bioscience, Inc. | 21.36M | 0.34% | 38,162 | -57.13K |
| 478 | GNTA | Genenta Science S.p.A. | 20.62M | 2.10% | 44,905 | - |
| 479 | PLRZ | Polyrizon Ltd. | 20.45M | -1.00% | 8,784 | - |
| 480 | CTXR | Citius Pharmaceuticals, Inc. | 20.36M | -2.26% | 1,795,273 | 3.94M |
| 481 | ALLR | Allarity Therapeutics, Inc. | 20.26M | -0.79% | 181,593 | - |
| 482 | INTS | Intensity Therapeutics, Inc. | 20.04M | 2.46% | 19,718 | - |
| 483 | VYNE | VYNE Therapeutics Inc. | 19.99M | -0.30% | 172,098 | 570.00K |
| 484 | INAB | IN8bio, Inc. | 19.43M | 9.94% | 102,010 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 18.97M | 0.38% | 21,325 | - |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 18.24M | -2.50% | 30,726 | - |
| 487 | IOBT | IO Biotech, Inc. | 17.99M | -5.91% | 3,185,936 | - |
| 488 | LEXX | Lexaria Bioscience Corp. | 17.72M | -2.20% | 150,155 | 522.00K |
| 489 | HOTH | Hoth Therapeutics, Inc. | 17.69M | 13.43% | 1,360,122 | - |
| 490 | LGVN | Longeveron Inc. | 17.33M | -8.81% | 6,079,716 | 1.44M |
| 491 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 16.42M | 7.66% | 183,732 | - |
| 492 | SER | Serina Therapeutics, Inc. | 16.18M | -7.41% | 51,901 | 116.00K |
| 493 | TRAW | Traws Pharma, Inc. | 15.90M | 15.03% | 133,300 | 2.85M |
| 494 | ACXP | Acurx Pharmaceuticals, Inc. | 15.36M | 107.93% | 106,602,279 | - |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | 2.44% | 285,963 | - |
| 496 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.29M | -1.13% | 58,227 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 14.06M | -4.23% | 24,600 | - |
| 498 | GTBP | GT Biopharma, Inc. | 13.88M | 5.67% | 904,244 | - |
| 499 | CRIS | Curis, Inc. | 13.83M | - | 50,889 | 11.65M |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 13.77M | -2.27% | 183,279 | - |
| 501 | BCAB | BioAtla, Inc. | 13.75M | -1.57% | 990,149 | 11.00M |
| 502 | BCDA | BioCardia, Inc. | 13.69M | 1.57% | 50,300 | 3.00K |
| 503 | KAPA | Kairos Pharma, Ltd. | 13.13M | -1.45% | 156,084 | - |
| 504 | CLRB | Cellectar Biosciences, Inc. | 12.55M | -2.95% | 36,203 | - |
| 505 | SNGX | Soligenix, Inc. | 12.41M | - | 141,599 | 2.34K |
| 506 | NCEL | NewcelX Ltd. | 12.35M | 3.44% | 32,627 | - |
| 507 | OSRH | OSR Holdings, Inc. | 12.19M | -5.02% | 266,939 | -90.52K |
| 508 | CMMB | Chemomab Therapeutics Ltd. | 12.06M | -1.01% | 55,207 | - |
| 509 | GDTC | CytoMed Therapeutics Limited | 11.89M | -2.83% | 8,135 | 573.19K |
| 510 | BLRX | BioLineRx Ltd. | 11.87M | -1.16% | 2,386 | 12.74M |
| 511 | AKTX | Akari Therapeutics, Plc | 11.82M | 1.56% | 176,688 | - |
| 512 | LIMN | Liminatus Pharma, Inc. | 11.44M | 5.33% | 3,093,327 | - |
| 513 | QNTM | Quantum BioPharma Ltd. | 11.27M | -25.00% | 809,618 | - |
| 514 | CALC | CalciMedica, Inc. | 10.89M | 2.50% | 318,105 | - |
| 515 | BIVI | BioVie Inc. | 10.63M | 2.92% | 47,735 | - |
| 516 | IMNN | Imunon, Inc. | 10.58M | 0.65% | 13,007 | - |
| 517 | KALA | KALA BIO, Inc. | 10.31M | 24.16% | 288,949,964 | - |
| 518 | MBRX | Moleculin Biotech, Inc. | 10.01M | 3.05% | 118,436 | - |
| 519 | ICU | SeaStar Medical Holding Corporation | 9.99M | 2.97% | 71,637 | 881.00K |
| 520 | PHGE | BiomX Inc. | 9.94M | -16.80% | 122,587 | - |
| 521 | ITRM | Iterum Therapeutics plc | 9.03M | -5.99% | 637,328 | 390.00K |
| 522 | CLGN | CollPlant Biotechnologies Ltd. | 8.80M | -1.63% | 18,846 | 2.48M |
| 523 | RNAZ | TransCode Therapeutics, Inc. | 8.78M | -0.88% | 5,857 | - |
| 524 | CDIO | Cardio Diagnostics Holdings, Inc. | 8.69M | -4.61% | 378,407 | 15.78K |
| 525 | ALZN | Alzamend Neuro, Inc. | 8.29M | 1.87% | 57,175 | - |
| 526 | TOVX | Theriva Biologics, Inc. | 8.20M | 0.45% | 1,005,473 | - |
| 527 | NCNA | NuCana plc | 8.12M | -2.99% | 62,726 | - |
| 528 | PULM | Pulmatrix, Inc. | 8.07M | -0.90% | 7,620 | 3.00K |
| 529 | KPRX | Kiora Pharmaceuticals, Inc. | 7.96M | -0.46% | 20,063 | 20.00K |
| 530 | BOLT | Bolt Biotherapeutics, Inc. | 7.93M | -3.05% | 11,354 | 5.20M |
| 531 | ERNA | Ernexa Therapeutics Inc. | 7.90M | -3.38% | 2,090,978 | 1,000.00 |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.74M | -0.57% | 5,599 | 6.00K |
| 533 | GRDX | GridAI Technologies Corp. | 7.70M | -0.87% | 66,018 | - |
| 534 | IMRN | Immuron Limited | 7.47M | -5.42% | 22,914 | 4.99M |
| 535 | PMCB | PharmaCyte Biotech, Inc. | 7.30M | - | 68,587 | - |
| 536 | MLEC | Moolec Science SA | 7.25M | -4.73% | 15,037 | 7.83M |
| 537 | MBIO | Mustang Bio, Inc. | 7.22M | - | 19,696 | - |
| 538 | CELZ | Creative Medical Technology Holdings, Inc. | 6.95M | 2.58% | 12,250 | 6.00K |
| 539 | ADXN | Addex Therapeutics Ltd | 6.76M | 0.81% | 1,345 | 198.82K |
| 540 | EVGN | Evogene Ltd. | 6.62M | -4.96% | 131,120 | 3.85M |
| 541 | APM | Aptorum Group Limited | 6.54M | 1.32% | 13,403 | - |
| 542 | PCSA | Processa Pharmaceuticals, Inc. | 6.53M | -1.37% | 45,366 | - |
| 543 | XTLB | XTL Biopharmaceuticals Ltd. | 6.45M | 2.67% | 22,555 | 968.00K |
| 544 | ASBP | Aspire Biopharma Holdings, Inc. | 6.28M | 2.46% | 70,090 | 1.94K |
| 545 | QNCX | Quince Therapeutics, Inc. | 6.05M | 4.42% | 45,978,460 | - |
| 546 | PPBT | Purple Biotech Ltd | 6.03M | -4.98% | 11,313 | - |
| 547 | BRTX | BioRestorative Therapies, Inc. | 5.96M | -2.32% | 8,729,188 | 383.40K |
| 548 | XBIO | Xenetic Biosciences, Inc. | 5.89M | -2.65% | 14,821 | 2.86M |
| 549 | SLXN | Silexion Therapeutics Corp | 5.88M | - | 9,628 | - |
| 550 | PBM | Psyence Biomedical Ltd. | 5.71M | -0.80% | 9,138 | - |
| 551 | APRE | Aprea Therapeutics, Inc. | 5.50M | -5.29% | 110,048 | 488.24K |
| 552 | CYCN | Cyclerion Therapeutics, Inc. | 5.44M | -2.72% | 35,871 | 2.86M |
| 553 | CANF | Can-Fite BioPharma Ltd. | 5.40M | -3.57% | 62,308 | 560.00K |
| 554 | MTVA | MetaVia Inc. | 5.23M | 5.16% | 123,264 | - |
| 555 | VIVS | VivoSim Labs, Inc. | 5.06M | 2.11% | 35,225 | 142.00K |
| 556 | REVB | Revelation Biosciences, Inc. | 5.02M | 0.75% | 85,690 | - |
| 557 | SILO | Silo Pharma, Inc. | 4.85M | 5.05% | 241,261 | 72.10K |
| 558 | GOVX | GeoVax Labs, Inc. | 4.83M | -4.66% | 78,593 | 3.35M |
| 559 | GNPX | Genprex, Inc. | 4.64M | - | 196,851 | - |
| 560 | LNAI | Lunai Bioworks Inc. | 4.60M | -4.76% | 570,030 | - |
| 561 | BGMS | Bio Green Med Solution, Inc. | 4.50M | -3.44% | 34,975 | 81.00K |
| 562 | APVO | Aptevo Therapeutics Inc. | 4.41M | -15.00% | 187,740 | - |
| 563 | GRI | GRI Bio, Inc. | 4.25M | 6.91% | 88,663 | - |
| 564 | DCOY | Decoy Therapeutics Inc. | 4.18M | -4.84% | 267,450 | - |
| 565 | GLMD | Galmed Pharmaceuticals Ltd. | 4.16M | 3.17% | 8,933 | - |
| 566 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.14M | 71.28% | 56,918,869 | 1.36M |
| 567 | MTNB | Matinas BioPharma Holdings, Inc. | 4.09M | 5.75% | 10,711 | - |
| 568 | INDP | Indaptus Therapeutics, Inc. | 3.97M | -5.35% | 53,902 | - |
| 569 | OGEN | Oragenics, Inc. | 3.77M | -9.90% | 1,509,913 | - |
| 570 | DRMA | Dermata Therapeutics, Inc. | 3.13M | 3.15% | 139,190 | - |
| 571 | AZTR | Azitra, Inc. | 3.10M | -6.54% | 1,184,760 | 7.50K |
| 572 | XRTX | XORTX Therapeutics Inc. | 3.08M | 0.41% | 15,321 | - |
| 573 | HCWB | HCW Biologics Inc. | 3.02M | -6.58% | 105,709 | 422.03K |
| 574 | ARTL | Artelo Biosciences, Inc. | 2.93M | 2.22% | 62,164 | - |
| 575 | ADIL | Adial Pharmaceuticals, Inc. | 2.81M | 7.65% | 112,666 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 2.74M | -0.51% | 40,003 | - |
| 577 | SCNI | Scinai Immunotherapeutics Ltd. | 2.62M | 1.08% | 24,046 | 1.15M |
| 578 | JAGX | Jaguar Health, Inc. | 2.56M | 19.99% | 639,198 | 11.79M |
| 579 | CLDI | Calidi Biotherapeutics, Inc. | 2.55M | -3.89% | 404,446 | - |
| 580 | CDT | CDT Equity Inc. | 2.54M | -8.11% | 187,429 | - |
| 581 | ELAB | PMGC Holdings Inc. | 2.41M | -0.06% | 85,689 | 285.95K |
| 582 | LYRA | Lyra Therapeutics, Inc. | 2.33M | 0.77% | 16,547 | 600.00K |
| 583 | BBLG | Bone Biologics Corporation | 2.30M | - | 7,710 | - |
| 584 | PPCB | Propanc Biopharma, Inc. | 2.22M | 2.34% | 2,606,602 | - |
| 585 | SPRC | SciSparc Ltd. | 2.18M | -4.23% | 27,475 | 1.31M |
| 586 | CNSP | CNS Pharmaceuticals, Inc. | 1.84M | -11.64% | 95,161 | - |
| 587 | CMND | Clearmind Medicine Inc. | 1.68M | -6.28% | 285,837 | - |
| 588 | ENSC | Ensysce Biosciences, Inc. | 1.66M | -7.28% | 636,108 | 4.49M |
| 589 | VRAX | Virax Biolabs Group Limited | 1.51M | 0.35% | 162,457 | 2.99K |
| 590 | ONCO | Onconetix, Inc. | 971.88K | 8.04% | 124,750 | 1.22M |
| 591 | BDRX | Biodexa Pharmaceuticals Plc | 766.65K | -3.78% | 49,712 | 104.90K |
| 592 | ADTX | Aditxt, Inc. | 593.86K | - | 103,068 | 5.95K |